Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure
Unknown statusNot applicableNCT05598164
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is aimed at studying the effectiveness and safety of surgical treatment of chronic anal fissure.
Study details
- Official title
- Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure Without Excision
- Conditions
- Chronic Anal Fissure
- Interventions
- Other: Botulinum toxin type A
- Sponsor
- State Scientific Centre of Coloproctology, Russian Federation
- Start date
- 2022-09-01
- Primary completion
- 2023-05-01
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Russia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with chronic anal fissure with spasm of anal sphincter Exclusion Criteria: * Inflammatory diseases of the colon * Pectenosis * Previous surgical interventions on the anal canal * IV grade internal and external hemorrhoids * Rectal fistula * Severe somatic diseases at the decompensation stage * Pregnancy and lactation * Anal sphincter insufficiency * Chronic paraproctitis * Fibrous polyp of the anal canal, accompanied by clinical manifestations * Individual intolerance and hypersensitivity to botulinum toxin * Myasthenia gravis and myasthenic syndromes
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05598164